Torti Frank

Torti Frank is listed in filings as President and Vant Chair at Roivant Sciences Ltd. - Common Shares. This profile follows SEC Form 4 activity through Apr 9, 2026, including sale activity. Recent filings connect the profile to Roivant Sciences Ltd. - Common Shares (ROIV) and Immunovant, Inc. (IMVT). The current snapshot covers public activity from Apr 3, 2025 to Apr 9, 2026. Reported amounts are shown as $1.5M to $38.4M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.